Microcarriers have been successfully used for many years for growing anchorage-dependent cells and as a means of delivering cells for tissue repair. When cultured on microcarriers, the number of anchorage-dependent cells, including primary cells, can easily be scaled up and controlled to generate the quantities of cells necessary for therapeutic applications. Recently, stem cell technology has been recognized as a powerful tool in regenerative medicine, but adequate numbers of stem cells that retain their differentiation potential are still difficult to obtain. For anchorage-dependent stem cells, however, microcarrier-based suspension culture using various types of microcarriers has proven to be a good alternative for effective ex vivo expansion. In this article, we review studies reporting the expansion, differentiation, or transplantation of functional anchorage-dependent cells that were expanded with the microcarrier culture system. Thus, the implementation of technological advances in biodegradable microcarriers, the bead-to-bead transfer process, and appropriate stem cell media may soon foster the ability to produce the numbers of stem cells necessary for cellbased therapies and/or tissue engineering.
INTRODUCTION
cells with identical properties (36, 87) . The key to successful large-scale and long-term cell culture is a welldefined and controlled bioreactor design. Stirred bio-Cell transplantation has been widely used in regenerative medicine or tissue engineering applications for many reactors (for suspension culture) can overcome several drawbacks of static cultures, including the presence of years (32, 37, 57, 100) . The most well-established therapeutic applications of cells grown in suspension are concentration gradients and difficulties in monitoring and control. Except for hematopoietic cells (38) , how-blood transfusion and transplantation of hematopoietic stem cells (52, 58, 66) . The key to successful transplanta-ever, mammalian cells are usually expanded as anchorage-dependent cells, and therefore development of a cul-tion using cell-based technologies is the preparation of large enough numbers of high-quality cells. Similar to ture system with suitable support is necessary. The stirred microcarrier culture system can facilitate the cells grown in suspension, anchorage-dependent cellbased transplantation, such as the use of islet cells for expansion of cells that require attachment, and provides an environment that can easily be controlled and moni-diabetes (6, 78) , bone marrow cells for myocardial infarct (31, 47, 79) , or critical limb ischemia (3), requires tored. In addition, owing to their capacity for self-renewal at least 1-2 × 10 9 cells for an adult patient (50-100 kg). Thus, the development of a practical and scalable bio-and differentiation, stem cells such as embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), process that allows expansion and transplantation of functional cells would potentiate cell-based therapies. mesenchymal stem cells (MSCs), and other adherent stem/progenitor cells have been recognized for their Many culture systems have been designed to expand great potential in regenerative medicine. To realize the In this article, the microcarrier culture systems used for primary cells, adult stem cells, and embryonic stem potential of stem cell-based therapies, however, technical improvements in the large-scale expansion of stem cells are reviewed as follows. cells and their differentiated progeny are required. Mi-PRIMARY CELLS crocarriers may be an alternative culture system for producing significant quantities of cells that are required for Microcarriers have the benefit of delivering cells to damaged or degenerated tissue for repair and restoration future clinical product development.
of function. Several studies have shown that primary MICROCARRIERS cells cultured on microcarriers and implanted into animal models can cure several disorders for many years. The microcarrier culture system was introduced by van Wezel in 1967 and has been applied successfully to Table 1 summarizes a number of examples of microcarriers that have been used in animal models. These stud-the growth of anchorage-dependent cells for the production of vaccines or pharmaceuticals, and to expand cell ies have provided crucial information about liver insufficiency (20-22), cartilage repair (35, 49, 85) , skin repair populations (88) . This culture system offers the advantage of providing a larger surface area for the growth of (44, 89, 90) , and Parkinson's disease (12,14,73). In 1986, Demetriou et al. first reported a new method anchorage-dependent cells in a suspension culture system, and overcomes several problems with static cul-for expansion of primary hepatocytes with Cytodex 3 (dextran matrix with a layer of collagen) and the subse-tures, including the requirement for large quantities of culture media, space expense, inefficient gas-liquid ox-quent hepatocyte transplantation that results in prolonged hepatocyte viability and function in vivo (20, 22) . ygen transfer, presence of concentration gradients, and difficulties in monitoring and control.
In addition, transplantation of microcarrier-attached hepatocytes had a curative effect and provided sufficient Although the microcarrier culture system has many advantages, the limitation of cell attachment to the mi-metabolic support, detoxification of ammonia, and an increase in the survival rates of liver-damaged rats crocarrier surface depends on the carrier diameter (typically in the range of 100-400 µm), density (typically (54, 98) . Recently, Xu et al. described the positive effects of intraperitoneal transplantation of Cytodex 3 microcar-between 1.02 and 1.10 g/ml), and chemical composition (48). Today, microcarriers are commonly composed of rier-attached hepatocytes in rats with acute liver failure induced by D-galactosamine (98). Additionally, a micro-a dextran matrix, with diethylaminoethyl (DEAE) anion exchange groups being widely used. This group of mi-carrier-attached hepatocyte-based bioartificial liver also facilitated metabolic support and modified the humoral crocarriers includes Cytodex TM 1, Cytodex 2, and Hillex TM . In addition, Cytodex 3 is also a member of the response in an experimental therapy for liver failure (81, 97) . DEAE-dextran family, but the Cytodex 3 microcarriers are coated with a thin layer of collagen (48). The other For skin repair, Voigt et al. first reported that Cytodex 3 microcarrier-attached keratinocytes provide a new materials that are used for microcarriers include plastic, glass, and cellulose. However, the aforementioned mi-multilayered and keratinized epithelium in a full-thickness wound healing model, but the microspheres could crocarriers are less amenable in tissue engineering or direct transplantation because they cannot be decomposed not be degraded and induced an inflammatory response (90) . Therefore, this group investigated another biode-by the human body. Trypsin, collagenase, and dispase have been used to retrieve viable cells from nonbiode-gradable substance, PLGA microcarriers, which were coated with gelatin and recombinant human epidermal gradable microcarriers for use in cell-based transplantation studies. However, perfect separation of the cells growth factor. At 14 days posttransplantation, a new stratified epithelium was detected in the full-thickness from nonbiodegradable microcarriers after enzyme treatment is still difficult. Therefore, development of micro-wound healing model (89) . Recently, Liu et al. produced autologous melanocytes, keratinocytes, and fibroblasts carriers composed of biodegradable chemicals may be an ideal answer. on a large scale using the CultiSpher-G microcarrier culture system (41-44), and showed a decrease in the size Recently, microcarriers made of biodegradable substances including gelatin (CultiSpher TM family) (49), col-of recalcitrant venous leg ulcers using autologous keratinocytes (44). Using the novel bioreactor microcarrier lagen (Cellagen TM ) (30), poly-lactic-co-glycolic acid (PLGA) (85) , poly-L-lactic acid (PLLA) (19) , and hy-cell culture system (Bio-MCCS) of Liu et al., autologous human keratinocytes can be rapidly expanded on one droxyapatite (26) have raised great interest and been extensively studied for their clinical application in the field specific type of modified CultiSpher-G microcarriers, which are first cultured with autologous dermal fibro-of regenerative medicine. In addition, cell-seeded microcarriers can be used to transport cells to the tissue(s) that blasts that are killed when they reach confluency (43). For cartilage repair, Malda et al. reported that human needs to be repaired. cytes results in a reconstituted epithelium that is multilayered and keratinized.
Human PLGA Full-thickness wound heal-Approach to expand cultured human keratinocytes 89 ing model (nude mice) and reconstitute the epidermis in full-thickness wounds using a new microspherical transport system.
Human
CultiSpher-G Skin transplants (human) Transplantation of microcarrier-attached keratino-44 cytes decreases the size of recalcitrant venous leg ulcers.
Cytoline 1 TM (poly-Skin transplants (human) Wounds heal in a shorter time and a better condi-9 ethylene and silica) tion is achieved with the treatment. Microcarriers only do not have a curative effect.
CultiSpher-G Skin transplants (in vitro hu-Microcarrier-expanded keratinocytes seeded onto 11 man skin equivalent model) the 3D in vitro human skin equivalent model are able to produce a viable epidermis. When keratinocytes are cocultured with feeder cells on microcarriers, a slightly greater cell yield is observed compared to keratinocytes cultured on microcarriers without feeder cells. reducing rotation for at least eight months, but animals implanted with cells alone show a reduction in rotation that lasted less than 3 months.
Rat Cytodex 3 glass
Parkinson's disease (rat) Animals that receive adrenal chromaffin cells-12 beads beads show significant behavioral recovery that is sustained over the 12-month test period, but the group that received adrenal chromaffin cells alone only exhibited a significant reduction in the first month.
Ventral mesencephalon cells Human and rat
Cytodex microcar-Parkinson's disease (rat) Microcarriers provide enhanced survival of both 73 riers (no article) rat allograft and human xenograft fetal mesencephalic cells in the rat striatum.
Retinal pigment epithelial cells Human
Gelatin microcar-Parkinson's disease (rat) These results further support the possibility that 14 rier implantation of cultured hRPE cells may be a promising therapeutic option for patients with Parkinson's disease.
PLLA, poly-L-lactic acid; PLGA, poly-lactic-co-glycolic acid; hRPE, human retinal pigment epithelium.
nasal chondrocytes could be expanded on CultiSpher-G and differentiation of anchorage-dependent cells (e.g., fibroblasts, osteoblasts, and MSCs), and may be useful microcarriers, and that the collagen content of microcarrier-expanded chondrocytes 14 days after implantation in clinical regenerative medicine in the musculoskeletal or dermatological fields (91,92). was slightly higher than T-flask-expanded cells (49) . In addition to expansion on gelatin-based microcarriers, ADULT STEM CELLS expansion of chondrocytes on PLGA microcarriers demonstrated the feasibility of articular cartilage repair in a
The technologies described above have encouraged the use of the microcarrier culture system as a powerful mouse model (35, 85) . In addition, gelatin microcarrierbased cell delivery has shown positive clinical results in tool for expansion of stem cells for clinical use. Moreover, the use of microcarriers in expansion, differentia-Parkinson's disease using human retinal pigment epithelial cells (14, 27, 93) . tion, and transplantation has only been explored to a limited extent. Tables 2 and 3 list currently available Furthermore, other biodegradable natural polysaccharides and FDA-approved hydrogel-based microcarriers information about stem cells cultured on microcarriers. Moreover, this system also makes possible the use of have been shown to facilitate adhesion, proliferation, but increases G-actin and cellular lipid content (adipogenesis). continuous bioprocesses to expand and recover human successful tissue engineering with MSCs (8,61,68), technological problems remain, such as a time-and money-stem cells for subsequent use in clinical cellular therapies or tissue engineering. As illustrated in Figure 1 , consuming expansion phase due to a long expansion period and a labor-intensive process. Therefore, the de-there are three suitable bioreactors for stem cell expansion or differentiation on microcarriers and three pro-velopment of bioreactors that allow monitoring, control, and automation of the cell culture process will be deci-spective methods of stem cell recovery as well as direct injection for the repair of tissues such as brain, skin, sively important. The ability of MSCs to attach, proliferate, and differ-liver, bone, and cartilage. entiate on macroporous microcarriers in spinner culture Mesenchymal Stem Cells has been confirmed (71,95,99) (Fig. 2) . The culture of MSCs on microcarriers was first explored by Wu et al. Owing to their high plasticity (8,15,61,65,68,83), high expansion capacity (65, 82, 83) , and ability to avoid in 2003 (95) ; the results showed that 7 days of cultivation yielded a 10-fold increase in viable cells in spinner rejection after transplantation (72), these adult stem cells are likely to play a prominent role in regenerative medi-culture, and that the average lactate yield from glucose consumption in the spinner culture was only 1.63, which cine. Although some clinical studies have demonstrated is lower than that in stationary culture (2.44). Addition-hance the performance of tissue engineering approaches for cartilage and bone repair. Rubin et al. reported a ally, after growth in the spinner culture for 12 days, the MSCs maintained the characteristics of stem cells (95) . strategy for the proliferation and differentiation of adipose-derived stem cells on CultiSpher-G microcarriers Recently, the effect of porcine bone marrow mesenchymal stem cell (BMMSC) proliferation using three types that would allow induction of differentiation ex vivo, precise placement of cells, and correct tissue architec-of commonly available Cytodex microcarriers was examined by Frauenschuh et al. The results showed that ture (71) . In addition, Yang et al. reported that shortterm direct subcutaneous transplantation of BMMSCs Cytodex 1 microcarriers promoted a higher level of cell attachment and proliferation compared with Cytodex 2 expanded on CultiSpher-S microcarriers was associated with significantly less apoptosis than trypsinized control and 3 (29) . In addition, this group also demonstrated increased colonization of microcarriers after carrier ad-cells, and that induction of de novo trabecular bone formation in vivo occurred in the long term (99). dition in a 1:1 ratio after almost all microcarriers had become confluent (bead-to-bead transfer) (29) . Recently, In addition to the CultiSpher family, hydroxyapatite microparticles-another type of biodegradable micro-the microcarrier culture scalability of ear MSCs was expanded with bead-to-bead transfer, and cells maintained carrier that varies in size and microporosity-were evaluated in vitro and in vivo for their suitability for use as their potential for differentiation (75). Also, addition of 30% fresh medium containing microcarriers every 3 a carrier in an injectable tissue-engineered bone filler. Fischer et al. showed that both the size and microporos-days provided decreased production of lactate from glucose and continuous proliferation of goat MSCs on mi-ity of nonporous hydroxyapatite microparticles affect in vivo bone formation by cultured mesenchymal progeni-crocarriers (76). In addition, a more homogenous cell distribution on the microcarriers was obtained as a result tor cells. The diameter particle size range of 212-300 mm is optimal for use as carriers of cultured goat mes-of bead-to-bead transfer (76). Based on the use of beadto-bead transfer, the available area can be extended and enchymal progenitor cells for the in vivo production of bone tissue (26) . the culture of anchorage-dependent cell can be prolonged by free cells colonizing from old beads to fresh In some specific cases, MSCs can be cultured on microcarriers in a microgravity environment modeled by a beads (60) .
Recently, adult MSCs have been proposed as attrac-rotary cell culture system (51, 102) . Zayzafoon et al. first indicated that microgravity modeled by a rotating wall tive candidates for regenerative therapy of connective tissues. MSC-seeded microcarriers may simplify and en-vessel bioreactor inhibits osteoblastic differentiation of human MSCs on plastic microcarriers and induces the the medium and inoculation conditions are critical for robust cell proliferation. The best growth characteristics development of an adipocytic lineage phenotype (102). After 1 year, Meyers et al. confirmed that reduced osteo-for mammalian neural stem cells were obtained with a pH range of 7.1-7.5, a high oxygen level (20%), and blastogenesis and enhanced adipogenesis of human MSCs on plastic microcarriers in modeled microgravity low osmolarity of the medium (below 400 mOsm/kg). Kallos and coworkers also proposed optimal serial pas-were mediated by RhoA and cytoskeletal disruption (51) . These reports suggest a possible reason for the re-saging protocols that would allow mammalian neural stem cells to be grown effectively in suspension culture duced bone mass of the human body after prolonged time in space, but also imply that this culture system (34). For the first time, this group was able to grow mammalian neural stem cells on a larger scale in suspen-cannot maintain the differentiation potential of MSCs. sion culture and maintain their stem cell characteristics.
Neural Stem Cells
Pancreatic Stem Cells Kallos and Behie first reported the growth and inoculation conditions for the large-scale expansion of mam-Adult pancreatic stem cells can be grown for more than 140 passages while maintaining the expression of malian neural stem cells in suspension bioreactors (33) . These investigators showed that optimization of pH of typical stem cell markers (39) . Serra et al. evaluated two different culture strategies, including cell aggregated well (67) . In addition, recent studies have described the successful use of feeder-free (with feeder-conditioned culture and the microcarrier culture system. The use of a microcarrier support (Cytodex 1 or Cytodex 3) pro-medium but without feeder cell coculture) and feederindependent systems (without conditioned medium or moted the expansion of cell populations that retained their self-renewal ability, cell markers, and differentia-feeder coculture) with appropriate extracellular matrix molecules, such as Matrigel TM , laminin, fibronectin, col-tion potential, allowing them to differentiate into adipocytes (77) . In addition, although both Cytodex 1 and Cy-lagen IV, and vitronectin, for human ESC culture (4, 5, 46, 69, 96) . Thus, the current methods for scaling up todex 3 could sustain cell expansion, Cytodex 3 was a better substrate for the promotion of cell adherence and ESC culture using microcarriers have focused on the extracellular matrix molecules present on the surface of growth.
microcarriers.
Progenitor Cells
In 2005, Fok and Zandstra first reported a method in which glass-coated styrene microcarriers and Cytodex 3 Melero-Martin et al. reported that the use of Culti Spher-G microcarriers resulted in a 17-fold expansion of were used to establish a feeder-free microcarrier culture system for mouse ESCs, which resulted in shorter dou-chondro-progenitor cells grown in batch cultures (50) . In addition, chondro-progenitor cells were capable of bling times than substrate-free aggregate cultures grown in suspension (28) . The effects of inoculation of mouse undergoing bead-to-bead migration, which allowed subcultivation without a harvesting step. In addition to ESCs and the concentration of Cytodex 3 on cell growth and metabolism were analyzed by Abranches et al. (1) . chondro-progenitor cells, Sugo and Ogawa also reported that rat bone marrow cells grown on hydroxyapatite mi-After seeding, the cells typically exhibited a growth curve consisting of a short death or lag phase followed crocarriers maintained the potential to differentiate into osteoblasts, and the cell proliferation was more rapidly by an exponential phase leading to a maximum cell density of 2.5-3.9 × 10 6 cells/ml and a maximum specific in the case of the hydroxyapatite microcarrier than in the case of hydroxyapatite disk or T75 flasks (80) . Barrias et growth rate of 1.2 day −1 (1). In addition, 46C mouse ESCs cultured on two different microcarriers were com-al. also reported that bone marrow stromal cells could grow and differentiate into osteoblastic lineage cells pared by Fernandes et al. (24) . The maximal fold increase in the population of these mouse ESCs cultured when expanded on calcium titanium phosphate microspheres (7). on macroporous CultiSpher-S was higher than that of cells cultured on Cytodex 3, but the maximum specific Hematopoietic Stem/Progenitor Cells growth rate was lower when cells were grown in serumcontaining conditions (24) . Hematopoietic stem/progenitor cells have been expanded or differentiated with or without coculture with It is possible to establish an economical and c-GMPcompliant microcarrier system to produce human fibro-bone marrow cells grown in microcarrier cultures (23, 74, 101 
